A Cambridge biotech is the worst-performing IPO so far this year nationally
March 29, 2018 at 12:21 PM EDT
Renaissance Capital issued its quarterly roundup of the U.S. IPO market, including a list of the companies whose shares have decreased the most since hitting the Nasdaq.
